Share this article

UK-based engineered antibodies manufacturer Absolute Antibody Ltd has merged with KeraFAST Inc, a life science research company based in the US.

Both companies will retain their names and employees under one combined organisation.

The merger will enhance the global reach of the two companies and enable them to provide custom services to their customers.

Charles River Laboratories International Inc has agreed to purchase MPI Research Inc for $800m.

Charles River is a pre-clinical and clinical laboratory services provider, while the MPI offers contract research. Both companies are based in the US.

The acquisition is scheduled to complete in Q2 2018 and will help Charles River enter growing end markets and scale-up production to meet demand.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

Charles River appointed Morgan Stanley & Co LLC as financial advisor, and Davis Polk & Wardwell LLP as legal advisor for the transaction. Jefferies LLC and SunTrust Robinson Humphrey Inc were appointed as financial advisors, and Weil, Gotshal & Manges LLP as legal advisor to MPI.

“The acquisition is scheduled to complete in Q2 2018 and will help Charles River enter growing end markets and scale-up production to meet demand.”

SGS SA has acquired Skin Investigation and Technology Hamburg GmbH (SIT).

SGS provides inspection, verification and testing services, while SIT is a dermatological contract research organisation (CRO). Both companies are based in Germany.

The acquisition will expand SGS’s consumer and retail service portfolio.

Zhejiang Starry Pharmaceutical Co Ltd plans to acquire Zhejiang Hisyn Pharmaceutical Co Ltd in a cash and share issue deal.

Based in China, Zhejiang Starry Pharmaceutical is a pharmaceutical raw materials and intermediates manufacturer.

Citigroup Securities Co Ltd has been appointed as the financial advisor, while Jincheng, Tongda & Neal is the legal advisor for the transaction by the acquirer company.